<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32735634</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>PYGM mRNA expression in McArdle disease: Demographic, clinical, morphological and genetic features.</ArticleTitle>
        <Pagination>
          <StartPage>e0236597</StartPage>
          <MedlinePgn>e0236597</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0236597</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0236597</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">McArdle disease presents clinical and genetic heterogeneity. There is no obvious association between genotype and phenotype. PYGM (muscle glycogen phosphorylase gene) mRNA expression and its association with clinical, morphological, and genetic aspects of the disease as a set have not been studied previously.</AbstractText>
          <AbstractText Label="METHODS">We investigated genetic variation in PYGM considering the number of PTCs (premature termination codon) per sample and compared mRNA expression in skeletal muscle samples from 15 patients with McArdle disease and 16 controls to PTCs number and different aspects of the disease.</AbstractText>
          <AbstractText Label="RESULTS">The main variant found was c.148C&gt;T (PTC-premature termination codon). Patients with two PTCs showed 42% mRNA expression compared to the control group. Most cases showed an inversely proportional relation among PTCs and mRNA expression. Association between mRNA expression and other aspects of the disease showed no statistically significant difference (p&gt; 0.05).</AbstractText>
          <AbstractText Label="DISCUSSION">mRNA expression is not useful as a predictor factor for the prognosis and severity of the disease. Different mechanisms as post-transcriptional events, epigenetics factors or protein function may be involved.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carvalho</LastName>
            <ForeName>Alzira A S</ForeName>
            <Initials>AAS</Initials>
            <Identifier Source="ORCID">0000-0002-5485-7937</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Neurociências- Laboratório de doenças neuromusculares da Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christofolini</LastName>
            <ForeName>Denise M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Ideia Fértil de Saúde Reprodutiva do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departamento de genética do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perez</LastName>
            <ForeName>Matheus M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de análises clínicas do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alves</LastName>
            <ForeName>Beatriz C A</ForeName>
            <Initials>BCA</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de análises clínicas do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodart</LastName>
            <ForeName>Itatiana</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Ideia Fértil de Saúde Reprodutiva do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Figueiredo</LastName>
            <ForeName>Francisco W S</ForeName>
            <Initials>FWS</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de estatística do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turke</LastName>
            <ForeName>Karine C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Medical student of Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feder</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de farmacologia da Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Junior</LastName>
            <ForeName>Marcondes C F</ForeName>
            <Initials>MCF</Initials>
            <Identifier Source="ORCID">0000-0003-0898-2419</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Neurologia da UNICAMP, Campinas, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nucci</LastName>
            <ForeName>Ana M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Neurologia da UNICAMP, Campinas, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fonseca</LastName>
            <ForeName>Fernando L A</ForeName>
            <Initials>FLA</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de análises clínicas do Centro Universitário Saúde ABC, Santo Andre, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>07</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018389">Codon, Nonsense</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.4.1.-</RegistryNumber>
          <NameOfSubstance UI="D024982">Glycogen Phosphorylase, Muscle Form</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018389" MajorTopicYN="N">Codon, Nonsense</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003710" MajorTopicYN="Y">Demography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015971" MajorTopicYN="Y">Gene Expression Regulation, Enzymologic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024982" MajorTopicYN="N">Glycogen Phosphorylase, Muscle Form</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006012" MajorTopicYN="N">Glycogen Storage Disease Type V</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>NO: The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32735634</ArticleId>
        <ArticleId IdType="pmc">PMC7394413</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0236597</ArticleId>
        <ArticleId IdType="pii">PONE-D-20-09063</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Dimaur S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Curr Mol Med; 2:189–196 (2002). 10.2174/1566524024605770
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1566524024605770</ArticleId>
            <ArticleId IdType="pubmed">11949935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitaoka Y. McArdle disease and exercise physiology. Biology; 3:157–166 (2014). 10.3390/biology3010157
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/biology3010157</ArticleId>
            <ArticleId IdType="pmc">PMC4009758</ArticleId>
            <ArticleId IdType="pubmed">24833339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quinlivan R, et al.
McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry; 81:1182–1188 (2010). 10.1136/jnnp.2009.195040
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2009.195040</ArticleId>
            <ArticleId IdType="pubmed">20861058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inal-Gültekin G, et al.
Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.
Neuromuscul Disord; 27:997–1008 (2017). 10.1016/j.nmd.2017.06.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2017.06.004</ArticleId>
            <ArticleId IdType="pmc">PMC5698850</ArticleId>
            <ArticleId IdType="pubmed">28967462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubowitz V, Sewry CA, Oldfors A. Muscle biopsy: a practical approach, 4th ed
Oxford: Saunders; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Martinuzzi A, et al.
Phenotype modulators in myophosphorylase deficiency. Ann Neurol; 53:497–502 (2003). 10.1002/ana.10499
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.10499</ArticleId>
            <ArticleId IdType="pubmed">12666117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogales-Gadea G, et al.
McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat; 36:669–678 (2015). 10.1002/humu.22806
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.22806</ArticleId>
            <ArticleId IdType="pubmed">25914343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurgel-Giannetti J, et al.
Clinical and molecular characterization of Mcardle’s disease in Brazilian patients.
Neuromolecular Med; 15:470–475 (2013). 10.1007/s12017-013-8233-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12017-013-8233-2</ArticleId>
            <ArticleId IdType="pubmed">23653251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarnopolsky M, et al.
Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing. Muscle Nerve; 27:359–366 (2003). 10.1002/mus.10330
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.10330</ArticleId>
            <ArticleId IdType="pubmed">12635123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubisch C, Wicklein EM, Jentsch TJ. Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation. Hum Mutat; 12:27–32 (1998). 10.1002/(SICI)1098-1004(1998)12:1&amp;lt;27::AID-HUMU4&amp;gt;3.0.CO;2-%23
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-1004(1998)12:1&amp;lt;27::AID-HUMU4&amp;gt;3.0.CO;2-%23</ArticleId>
            <ArticleId IdType="pubmed">9633816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Untergasser A, et al.
Primer3—new capabilities and interfaces. Nucleic Acids Res;40: e115 (2012). 10.1093/nar/gks596
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gks596</ArticleId>
            <ArticleId IdType="pmc">PMC3424584</ArticleId>
            <ArticleId IdType="pubmed">22730293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics; 13:134 (2012). 10.1186/1471-2105-13-134
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-13-134</ArticleId>
            <ArticleId IdType="pmc">PMC3412702</ArticleId>
            <ArticleId IdType="pubmed">22708584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res; 29: e45 (2001). 10.1093/nar/29.9.e45
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/29.9.e45</ArticleId>
            <ArticleId IdType="pmc">PMC55695</ArticleId>
            <ArticleId IdType="pubmed">11328886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA; 310:2191–2194 (2013). 10.1001/jama.2013.281053
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId>
            <ArticleId IdType="pubmed">24141714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felice K. J., Grunnet M. L. and Sima A. A. (1996). Selective atrophy of type 1 muscle fibers in McArdle’s disease. Neurology
47, 581–583. 10.1212/wnl.47.2.581
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/wnl.47.2.581</ArticleId>
            <ArticleId IdType="pubmed">8757045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohn TA, Noakes TD, Rae DE, Rubio JC, Santalla A, Nogales-Gadea G, et al.
McArdle disease does not affect skeletal muscle fibre type profiles in humans.
Biol Open.
2014. 
November
28;3(12):1224–7
10.1242/bio.20149548
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/bio.20149548</ArticleId>
            <ArticleId IdType="pmc">PMC4265760</ArticleId>
            <ArticleId IdType="pubmed">25432515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucia A, Nogales-Gadea G, Pérez M, Martín MA, Andreu AL, Arenas J. McArdle disease: what do neurologists need to know?
Nat Clin Pract Neurol; 4:568–577 (2008). 10.1038/ncpneuro0913
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncpneuro0913</ArticleId>
            <ArticleId IdType="pubmed">18833216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogales-Gadea G, et al.
Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat; 29:277–283 (2008). 10.1002/humu.20649
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.20649</ArticleId>
            <ArticleId IdType="pubmed">17994553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez-Cadenas I, et al.
Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease. Neurology. 25;61(10):1432–4 (2003). 10.1212/wnl.61.10.1432
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/wnl.61.10.1432</ArticleId>
            <ArticleId IdType="pubmed">14638972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Consuegra I, Asensio-Peña S, Ballester-Lopez, Francisco-Velilla R, Pinos T, Pintos-Morell G, et al.
Missense mutations have unexpected consequences: The McArdle disease paradigm. Hum Mutat; 39(10):1338–1343 (2018). 10.1002/humu.23591
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.23591</ArticleId>
            <ArticleId IdType="pubmed">30011114</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
